2 completed, 1 recruiting. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Hearing Loss Ototoxic: new trials by email Literature Review of Hearing Loss Ototoxic trials Research Report on Hearing Loss Ototoxic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Cancer Treatments on Speech Perception in Noise, Cognition, and Hearing-Related Quality of Life Chemotherapy, chemoradiation, radiation therapy - Cancer, Hearing Loss Ototoxic | Recruiting | Turku University Hospital | 250 | 2024-10-02 | 2025-04-16 | |
| SENS-401 to Prevent the Ototoxicity Induced by Cisplatin in Adult Subjects With a Neoplastic Disease SENS-401 (R-Azasetron Besylate) - Hearing Loss Ototoxic | Phase 2 | Completed | Sensorion | 48 | 2022-12-30 | 2026-07-02 |
| Protective Role of N-acetylcisteine From Cisplatin-induced Ototoxicity in Patients With Head and Neck Cancer N Acetylcysteine, Placebo Oral Tablet - Cisplatin Adverse Reaction, Hearing Loss Ototoxic | Not applicable | Completed | Hospital San Juan de Dios, Santiago | 45 | 2015-11-01 | 2018-01-17 |
Ototoxicity (2) · Cognitive Dysfunction (1) · Hearing Loss (1) · Neoplasms (1)
Chemically-Induced Disorders (2) · Drug-Related Side Effects and Adverse Reactions (2) · Ear Diseases (2) · Otorhinolaryngologic Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Radiation Injuries (2) · Wounds and Injuries (2) · Cognition Disorders (1) · Hearing Disorders (1) · Mental Disorders (1) · Nervous System Diseases (1) · Neurocognitive Disorders (1) · Neurologic Manifestations (1) · Sensation Disorders (1)
Acetylcysteine (1) · Chemoradiotherapy (1) · Drug Therapy (1) · Radiotherapy (1) · SENS-401 (1)
Hospital San Juan de Dios, Santiago (1) · Sensorion (1) · Turku University Hospital (1)
Chile (1) · Finland (1) · France (1)